Watch for Daridorexant, a New Orexin Antagonist for Insomnia

June 2022

Daridorexant (Quviviq) will join a crowded list of Rx insomnia meds.

It's a me-too orexin antagonist...in the same family as suvorexant (Belsomra) and lemborexant (Dayvigo). All are C-IVs.

Daridorexant will be touted to help patients fall asleep faster...stay asleep longer...and feel less tired during the day. Reps will also say it can be used nightly...with no max duration.

Get concise advice on drug therapy, plus unlimited access to CE

Hospital Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote